These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 16955683
1. Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development. Kadow J, Wang HG, Lin PF. Curr Opin Investig Drugs; 2006 Aug; 7(8):721-6. PubMed ID: 16955683 [Abstract] [Full Text] [Related]
2. Understanding the binding mode and function of BMS-488043 against HIV-1 viral entry. Da LT, Quan JM, Wu YD. Proteins; 2011 Jun; 79(6):1810-9. PubMed ID: 21465559 [Abstract] [Full Text] [Related]
3. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK. Virology; 2005 Sep 01; 339(2):213-25. PubMed ID: 15996703 [Abstract] [Full Text] [Related]
4. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors. Hamza A, Zhan CG. J Phys Chem B; 2006 Feb 16; 110(6):2910-7. PubMed ID: 16471901 [Abstract] [Full Text] [Related]
5. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Veazey RS, Klasse PJ, Schader SM, Hu Q, Ketas TJ, Lu M, Marx PA, Dufour J, Colonno RJ, Shattock RJ, Springer MS, Moore JP. Nature; 2005 Nov 03; 438(7064):99-102. PubMed ID: 16258536 [Abstract] [Full Text] [Related]
6. Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015). Li W, Lu L, Li W, Jiang S. Expert Opin Ther Pat; 2017 Jun 03; 27(6):707-719. PubMed ID: 28076686 [Abstract] [Full Text] [Related]
7. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions. Boussard C, Klimkait T, Mahmood N, Pritchard M, Gilbert IH. Bioorg Med Chem Lett; 2004 May 17; 14(10):2673-6. PubMed ID: 15109676 [Abstract] [Full Text] [Related]
8. Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction. Williams DH, Adam F, Fenwick DR, Fok-Seang J, Gardner I, Hay D, Jaiessh R, Middleton DS, Mowbray CE, Parkinson T, Perros M, Pickford C, Platts M, Randall A, Siddle D, Stephenson PT, Tran TD, Vuong H. Bioorg Med Chem Lett; 2009 Sep 01; 19(17):5246-9. PubMed ID: 19620004 [Abstract] [Full Text] [Related]
9. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications]. Azevedo-Pereira JM, Santos-Costa Q. Acta Med Port; 2008 Sep 01; 21(5):497-504. PubMed ID: 19187693 [Abstract] [Full Text] [Related]
10. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors. Teixeira C, Serradji N, Maurel F, Barbault F. Eur J Med Chem; 2009 Sep 01; 44(9):3524-32. PubMed ID: 19410340 [Abstract] [Full Text] [Related]
11. Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes. Ketas TJ, Schader SM, Zurita J, Teo E, Polonis V, Lu M, Klasse PJ, Moore JP. Virology; 2007 Aug 01; 364(2):431-40. PubMed ID: 17428517 [Abstract] [Full Text] [Related]
18. Identification of putative, stable binding regions through flexibility analysis of HIV-1 gp120. Tan H, Rader AJ. Proteins; 2009 Mar 01; 74(4):881-94. PubMed ID: 18704932 [Abstract] [Full Text] [Related]